Rheumatology (Oxford, England)
-
Publication Venue For
- Implications of the accuracy of diagnostic algorithms for systemic lupus on our understanding of racial disparities in pregnancy outcomes.. kead178. 2023
- Metabolomics analysis identifies a lipidomic profile in treatment-naïve juvenile dermatomyositis patients vs healthy control subjects.. 61:1699-1708. 2022
- Introduction. 57:V1. 2018
- Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint.. 56:1794-1803. 2017
- RAPID INHIBITION OF PROGRESSION OF STRUCTURAL DAMAGE WITH CERTOLIZUMAB PEGOL, A NOVEL SC PEGYLATED, FC-FREE ANTI-TNF. 48:I18-I18. 2009
- Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel.. 47:194-199. 2008
- Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists.. 46:1688-1693. 2007
- The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.. 46:1606-1611. 2007
- Immunophenotyping of chimeric cells in localized scleroderma.. 46:398-402. 2007
- Synovial fluid metabolites in osteonecrosis.. 46:523-528. 2007
- The effect of UVB on lupus skin: new light on the role of apoptosis in the pathogenesis of autoimmunity.. 45:500-501. 2006
- Linkage and association studies of discoidin domain receptor 1 (DDR1) single nucleotide polymorphisms (SNPs) in juvenile oligoarthritis.. 43:1138-1141. 2004
- Assessment of hand osteoarthritis: correlation between thermographic and radiographic methods.. 43:915-919. 2004
- International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.. 43:49-54. 2004
- Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.. 42:1452-1459. 2003
- Polymyositis as a manifestation of chronic graft-versus-host disease.. 42:34-39. 2003
- Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis.. 41:930-936. 2002
- Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis.. 41:462-465. 2002
- SAFETY FOLLOWING INITIATION OF RITUXIMAB IN GRANULOMATOSIS WITH POLYANGIITIS (GPA) OR MICROSCOPIC POLYANGIITIS (MPA): INTERIM ANALYSIS OF THE RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS REGISTRY (RAVER) 2017
- SAFETY UPDATE ON CERTOLIZUMAB PEGOL (CZP) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) 2010
- THE EFFICACY OF CERTOLIZUMAB PEGOL ADDED TO METHOTREXATE IS SUSTAINED OVER 2 YEARS IN THE TREATMENT OF RHEUMATOID ARTHRITIS 2010